10-08-2026 16:46 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Mankind Pharma Ltd.
 
BSE Code 543904
ISIN Demat INE634S01028
Book Value 409.39
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 1006884.19
P/E 46.18
EPS 52.80
Face Value 1  
Description ( As On June 2026 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  13  299960612  72.63  299960612  
  Foreign Promoter          
  Total Promoter  13  299960612  72.63  299960612  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  36  44889663  10.87  44889663  
  FI/Bank/Insurance  19  6366992  1.54  6366992  
  Govt          
  FII          
  Other  523  51179445  12.39  51179445  
  Total Institutions  578  102436100  24.8  102436100  
 Non-Institution          
  Bodies Corporate  598  4287989  1.04  4287989  
  Individuals          
  NRIs/OCBs  2832  213336  0.05  213336  
  Others  162694  6097941  1.48  6097941  
  Total Non-Institution  166124  10599266  2.57  10599266  
Total Non Promoter  166702  113035366  27.37  113035366  
          
  Depository Receipts          
          
Grand Total  166715  412995978  100  412995978  
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code | Reasearch Analyst Certificate
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.